与改碳水化合物抗原的瘤相关的细胞外微小囊触发了更强的抗瘤免疫反应
Juan Mo1, You Zou1, Bo-Han Li1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, and Chemical Biology Center, Peking University, Beijing 100191, People's Republic of China.
ACS applied materials & interfaces
|August 17, 2023
概括
研究人员设计了带有修改瘤抗原的细胞外微粒,以加强癌症免疫治疗. 这种方法提高了免疫性和稳定性,为新型抗癌疫苗提供了有前途的战略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 异常的糖化是癌症的一个关键特征,与瘤相关的碳水化合物抗原为免疫治疗的潜在标.
- 来自瘤的细胞外微囊具有免疫性,但其疗效低,稳定性差,半衰期短.
研究的目的:
- 用修改的瘤相关碳水化合物抗原设计细胞外微囊,以增强抗瘤免疫力.
- 为了研究这些改造的微粒的潜力,作为癌症疫苗的新平台.
主要方法:
- 代谢性寡糖体工程被用来构建一个过度表达抗原处理酶的细胞系.
- 用修饰的单糖基质被用于产生显示修饰瘤相关碳水化合物抗原的微粒.
主要成果:
- 与未经修改的囊泡相比,工程外细胞微囊泡显示出增强的免疫性和生物稳定性.
- 在瘤免疫中应用这些修改后的微粒细胞导致了免疫预防和免疫治疗结果的改善.
- 阐明了增强抗瘤免疫反应的潜在机制.
结论:
- 修改的细胞外微粒是开发更有效的基于碳水化合物的抗癌疫苗的有希望的策略.
- 这种方法为利用细胞外微囊来进行先进的瘤治疗和免疫预防提供了新的见解.
相关概念视频
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


